Antiarrhythmic Drugs [phsu]
acute [tmco]
Conversion [ftcn]
Atrial Fibrillation [patf]
flutter [patf]
Sinus rhythm [fndg]
Need [qlco]
Pharmacologic Agent [phsu]
acute [tmco]
Conversion [ftcn]
Atrial Fibrillation [patf]
Atrial Flutter [patf]
Sinus rhythm [fndg]
Assumed [inpr]
Great [qnco]
Clinical Medicine [bmod]
reasons [idcn]
learned [menp]
Atrial Fibrillation [patf]
Self [idcn]
Arrhythmia [patf]
limiting [ftcn]
Duration [tmco]
IMPACT [gngm]
Ability [orga]
Expired [orgf]
To [qlco]
PREVENT [phsu]
recurring [phpr]
Avoidance [menp]
Electrical [npop]
Mechanical [ftcn]
learned [menp]
Rapid atrial fibrillation [dsyn]
Termination [inpr]
limit [ftcn]
Need [qlco]
anticoagulation [topp]
Hospitalization [hlca]
medical care [fndg]
Direct current cardioversion [topp]
effective [qlco]
More [ftcn]
expense [qnco]
Attractive [qlco]
Patients [podg]
Pharmacologic [bmod]
Conversion [ftcn]
Agent [chvf]
Currently [tmco]
Available [ftcn]
indication [idcn]
Limited [ftcn]
General Population [popg]
cardiac patients [podg]
Including [ftcn]
Structural [spco]
Heart disease [dsyn]
Limited [ftcn]
Efficacy [qlco]
toxicity [qlco]
Best [qlco]
Study [mnob]
Agent [chvf]
ibutilide [orch, phsu]
Only [qnco]
Available [ftcn]
Risk [qlco]
ventricular [bpoc]
Not [ftcn]
Continued [idcn]
Interest [menp]
New [tmco]
Drugs [phsu]
indication [idcn]
New [tmco]
Drugs [phsu]
Straightforward [qlco]
Complex [qlco]
Easy [qlco]
Conduct [inbe]
Clinical Trials [resa]
examining [fndg]
Safety [hcpp]
Efficacy [qlco]
New [tmco]
Chemical [chem]
Entity [enty]
Dose [qnco]
Range [qnco]
Surrogate Marker [qlco]
Biological [bmod]
Effect [qlco]
Q-T interval [clna]
studies [lbpr]
Rigor [sosy]
Control [grup]
placebo [topp]
Conversion [ftcn]
Rate [acty]
Not [ftcn]
Interpretation [inpr]
Real [qlco]
Clinical [qlco]
Efficacy [qlco]
placebo [topp]
Subtraction [phpr]
Care [acty]
Target Population [popg]
Efficacy [qlco]
Safety [hcpp]
Highly [qlco]
Cohort [popg]
Dependent [qlco]
Safety [hcpp]
Major [qlco]
Concern [idcn]
Instance [idcn]
Arrhythmia [patf]
Termination [inpr]
ELECTIVE [topp]
Not [ftcn]
Issue [fndg]
considered [idcn]
Life threatening [idcn]
QT [qnco]
Drugs [phsu]
Finding [sosy]
Dose [qnco]
effective [qlco]
Not [ftcn]
Causing [ftcn]
Unacceptable [qlco]
Risk [qlco]
Torsade de Pointes [dsyn]
Transition [comd]
Oral [spco]
therapy [ftcn]
sorted [menp]
Out [spco]
Patients [podg]
Frequently [tmco]
Transition [comd]
Oral [spco]
Drug [phsu]
Intermediate [spco]
Term [tmco]
Atrial Remodeling [patf]
Hope [menp]
New [tmco]
Drugs [phsu]
tedisamil [orch, phsu]
Fill [acty]
Now [tmco]
Defined [cnce]
Therapeutic [topp]
void [orgf]
To [qlco]
Comprehensive [qlco]
studies [lbpr]
acute [tmco]
Oral [spco]
therapy [ftcn]
Provide [acty]
Physicians [prog]
Appropriate [qlco]
Guidance [hlca]
Clinical [qlco]
Complete [qlco]
Program [cnce]
Information [idcn]
New [tmco]
Chemical [chem]
Entity [enty]
Drugs [phsu]
Warfarin [hops, orch, phsu]
Target Population [popg]
New [tmco]
Drug [phsu]
Atrial [bpoc]
ventricular [bpoc]
Defibrillation Threshold [qnco]
larger [qnco]
Patients [podg]
Future [tmco]
Device [medd]
therapy [ftcn]
Atrial [bpoc]
ventricular [bpoc]
Indications [idcn]
development [phsf]
New [tmco]
Drugs [phsu]
acute [tmco]
Atrial Fibrillation [patf]
flutter [patf]
Termination [inpr]
Represent [acty]
New [tmco]
Clinical Research [resa]
State [geoa]
development [phsf]
Flux [npop]
Roadmap [inpr]
Efficacy [qlco]
Safety [hcpp]
Analysis [lbpr]
Put [acty]
Forward [spco]
SO [geoa]
Most [qnco]
Efficient [qlco]
Method [inpr]
development [phsf]
New [tmco]
Drugs [phsu]
Availability [ftcn]
New Agents [clas]
Chance [qlco]
Maintain [acty]
Sinus rhythm [fndg]
Group [idcn]
Including [ftcn]
Structural [spco]
Heart disease [dsyn]
coronary artery disease [dsyn]
Construction [topp]
Efficient [qlco]
Complete [qlco]
Plan, Development [inpr]
Challenge [clna]
